Clinical Trial: Evaluation of the Efficacy and Safety of Oral LW402 Tablets for the Treatment of Patients With Moderate-to-Severe Atopic Dermatitis

U.S., Jan. 28 -- ClinicalTrials.gov registry received information related to the study (NCT07370909) titled 'Evaluation of the Efficacy and Safety of Oral LW402 Tablets for the Treatment of Patients With Moderate-to-Severe Atopic Dermatitis' on Jan. 19.

Brief Summary: This Phase 3, double-blind (sponsor-open), multicenter, placebo-controlled study aims to evaluate the efficacy and safety of oral LW402 tablets in patients with moderate to severe atopic dermatitis.

Study Start Date: Jan. 30

Study Type: INTERVENTIONAL

Condition: Efficacy and Safety of LW402 Tablets in Patients With Moderate to Severe Atopic Dermatitis

Intervention: DRUG: LW402

LW402 tablets

DRUG: Placebo

LW402 placebo tablets

Recruitment Status: NOT_YET_RECRUITING ...